This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mantzoros, C. Articles by Trichopoulos, D. Search for Related Content PubMed PubMed Citation Articles by Mantzoros, C. Articles by Trichopoulos, D.

Adiponectin and Breast Cancer Risk

Division of Endocrinology and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center (C.M.), Boston, Massachusetts 02215; Department of Hygiene and Epidemiology, Athens University Medical School (E.P., N.D., C.C., M.D., D.M.A., D.T.), Athens 11527, Greece; Department of Epidemiology, Harvard School of Public Health (E.P., D.T.), Boston, Massachusetts 02115; Elena Venizelou Hospital (Y.P.), Athens 11521, Greece; Breast Unit, Second Department of Propedeutic Surgery, Athens University Medical School (C.M.), Athens 11527, Greece; BIOMED, International Diagnostic Center (E.S.), Athens 11528, Greece; Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (G.C.), Bethesda, Maryland 20892; and First Department of Pediatrics, Ag. Sophia Children’s Hospital, Athens University Medical School (G.C.), Athens 11527, Greece

Address all correspondence and requests for reprints to: Eleni Petridou, M.D., Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias, Goudi, Athens 115-27, Greece. E-mail: epetrid{at}med.uoa.gr.

Adiponectin, an adipocyte-secreted hormone, is closely and inversely associated with insulin resistance and was recently found to be inversely and independently associated with endometrial cancer. Because insulin resistance in the setting of obesity has also been associated with the development of breast cancer, we have hypothesized that decreased adiponectin levels might underlie the association between breast cancer and obesity/insulin resistance. We evaluated the association of adiponectin with the occurrence of breast cancer in a case-control study comprising 174 women with newly diagnosed, histologically confirmed breast cancer and 167 controls. We found an inverse, fairly strong, and statistically significant association of serum adiponectin with breast cancer (odds ratio, 0.84; 95% confidence interval, 0.71–0.99). Importantly, despite a fairly robust inverse association of adiponectin with breast cancer risk among postmenopausal women (odds ratio, 0.82; 95% confidence interval, 0.67–1.00), no such significant association between adiponectin and breast cancer was found among premenopausal women. The observed associations were independent of possible effects of major components of the IGF system, leptin, body mass index, sociodemographic variables, and known risk factors for breast cancer. Future studies are needed to prove causality and provide further insights into both the mechanisms underlying the actions of this hormone and its potential role in breast cancer.

Abbreviations: BMI, Body mass index; CI, confidence interval; IGFBP-3, IGF-binding protein-3; OR, odds ratio; VEGF, vascular endothelial growth factor.

This article has been cited by other articles:

				J H Rubenstein, J Y Kao, R D Madanick, M Zhang, M Wang, M B Spacek, J L Donovan, S D Bright, and N J Shaheen Association of adiponectin multimers with Barrett's oesophagus Gut, December 1, 2009; 58(12): 1583 - 1589. [Abstract] [Full Text] [PDF]

				R. C.M. van Kruijsdijk, E. van der Wall, and F. L.J. Visseren Obesity and Cancer: The Role of Dysfunctional Adipose Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2569 - 2578. [Abstract] [Full Text] [PDF]

				L. R. Teras, M. Goodman, A. V. Patel, M. Bouzyk, W. Tang, W. R. Diver, and H. S. Feigelson No Association between Polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and Postmenopausal Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2553 - 2557. [Abstract] [Full Text] [PDF]

				V Barresi, M Grosso, G Giuffre, G Tuccari, and G Barresi The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma J. Clin. Pathol., August 1, 2009; 62(8): 705 - 709. [Abstract] [Full Text] [PDF]

				S. Landskroner-Eiger, B. Qian, E. S. Muise, A. R. Nawrocki, J. P. Berger, E. J. Fine, W. Koba, Y. Deng, J. W. Pollard, and P. E. Scherer Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo Clin. Cancer Res., May 15, 2009; 15(10): 3265 - 3276. [Abstract] [Full Text] [PDF]

				M. S. Denzel, L. W. Hebbard, G. Shostak, L. Shapiro, R. D. Cardiff, and B. Ranscht Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer Clin. Cancer Res., May 15, 2009; 15(10): 3256 - 3264. [Abstract] [Full Text] [PDF]

				A. Yildirim, M. Bilici, K. Cayir, V. Yanmaz, S. Yildirim, and S. B. Tekin Serum Adiponectin Levels in Patients with Esophageal Cancer Jpn. J. Clin. Oncol., February 1, 2009; 39(2): 92 - 96. [Abstract] [Full Text] [PDF]

				H. K. Neilson, C. M. Friedenreich, N. T. Brockton, and R. C. Millikan Physical Activity and Postmenopausal Breast Cancer: Proposed Biologic Mechanisms and Areas for Future Research Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 11 - 27. [Abstract] [Full Text] [PDF]

				J. Liu, J. B.B. Lam, K. H.M. Chow, A. Xu, K. S.L. Lam, R. T. Moon, and Y. Wang Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1 Carcinogenesis, November 1, 2008; 29(11): 2195 - 2202. [Abstract] [Full Text] [PDF]

				C M Friedenreich and A E Cust Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects Br. J. Sports Med., August 1, 2008; 42(8): 636 - 647. [Abstract] [Full Text] [PDF]

				M. Lajous, M.-C. Boutron-Ruault, A. Fabre, F. Clavel-Chapelon, and I. Romieu Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1384 - 1391. [Abstract] [Full Text] [PDF]

				V. G. Kaklamani, M. Sadim, A. Hsi, K. Offit, C. Oddoux, H. Ostrer, H. Ahsan, B. Pasche, and C. Mantzoros Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk Cancer Res., May 1, 2008; 68(9): 3178 - 3184. [Abstract] [Full Text] [PDF]

				C. J Williams, N. Mitsiades, E. Sozopoulos, A. Hsi, A. Wolk, A.-P. Nifli, S. Tseleni-Balafouta, and C. S Mantzoros Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors Endocr. Relat. Cancer, March 1, 2008; 15(1): 289 - 299. [Abstract] [Full Text] [PDF]

				D Barb, A Neuwirth, C S Mantzoros, and S P Balk Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway Endocr. Relat. Cancer, December 1, 2007; 14(4): 995 - 1005. [Abstract] [Full Text] [PDF]

				D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF]

				M. Archanco, J. Gomez-Ambrosi, M. Tena-Sempere, G. Fruhbeck, and M. A. Burrell Expression of Leptin and Adiponectin in the Rat Oviduct J. Histochem. Cytochem., October 1, 2007; 55(10): 1027 - 1037. [Abstract] [Full Text] [PDF]

				Y.-F. Tian, C.-H. Chu, M.-H. Wu, C.-L. Chang, T. Yang, Y.-C. Chou, G.-C. Hsu, C.-P. Yu, J.-C. Yu, and C.-A. Sun Anthropometric measures, plasma adiponectin, and breast cancer risk Endocr. Relat. Cancer, September 1, 2007; 14(3): 669 - 677. [Abstract] [Full Text] [PDF]

				D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]

				L. Vona-Davis and D. P Rose Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206. [Abstract] [Full Text] [PDF]

				S. S. Tworoger, A. H. Eliassen, T. Kelesidis, G. A. Colditz, W. C. Willett, C. S. Mantzoros, and S. E. Hankinson Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1510 - 1516. [Abstract] [Full Text] [PDF]

				J. B. Richards, A. M. Valdes, K. Burling, U. C. Perks, and T. D. Spector Serum Adiponectin and Bone Mineral Density in Women J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1517 - 1523. [Abstract] [Full Text] [PDF]

				S. D. Hursting, N. P. Nunez, L. Varticovski, and C. Vinson The Obesity-Cancer Link: Lessons Learned from a Fatless Mouse Cancer Res., March 15, 2007; 67(6): 2391 - 2393. [Abstract] [Full Text] [PDF]

				A. Korner, K. Pazaitou-Panayiotou, T. Kelesidis, I. Kelesidis, C. J. Williams, A. Kaprara, J. Bullen, A. Neuwirth, S. Tseleni, N. Mitsiades, et al. Total and High-Molecular-Weight Adiponectin in Breast Cancer: In Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1041 - 1048. [Abstract] [Full Text] [PDF]

				K. Michalakis, C. J. Williams, N. Mitsiades, J. Blakeman, S. Balafouta-Tselenis, A. Giannopoulos, and C. S. Mantzoros Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 308 - 313. [Abstract] [Full Text] [PDF]

				G. A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study Am. J. Epidemiol., January 15, 2007; 165(2): 164 - 174. [Abstract] [Full Text] [PDF]

				D. M. Huffman, M. S. Johnson, A. Watts, A. Elgavish, I. A. Eltoum, and T. R. Nagy Cancer Progression in the Transgenic Adenocarcinoma of Mouse Prostate Mouse Is Related to Energy Balance, Body Mass, and Body Composition, but not Food Intake Cancer Res., January 1, 2007; 67(1): 417 - 424. [Abstract] [Full Text] [PDF]

				L. D. Yee, N. Williams, P. Wen, D. C. Young, J. Lester, M. V. Johnson, W. B. Farrar, M. J. Walker, S. P. Povoski, S. Suster, et al. Pilot Study of Rosiglitazone Therapy in Women with Breast Cancer: Effects of Short-term Therapy on Tumor Tissue and Serum Markers Clin. Cancer Res., January 1, 2007; 13(1): 246 - 252. [Abstract] [Full Text] [PDF]

				Y. Wang, J. B. Lam, K. S.L. Lam, J. Liu, M. C. Lam, R. L.C. Hoo, D. Wu, G. J.S. Cooper, and A. Xu Adiponectin Modulates the Glycogen Synthase Kinase-3{beta}/{beta}-Catenin Signaling Pathway and Attenuates Mammary Tumorigenesis of MDA-MB-231 Cells in Nude Mice Cancer Res., December 1, 2006; 66(23): 11462 - 11470. [Abstract] [Full Text] [PDF]

				H. Motoshima, B. J. Goldstein, M. Igata, and E. Araki AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer J. Physiol., July 1, 2006; 574(1): 63 - 71. [Abstract] [Full Text] [PDF]

				A M Lorincz and S Sukumar Molecular links between obesity and breast cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 279 - 292. [Abstract] [Full Text] [PDF]

				S. de Assis, M. Wang, S. Goel, A. Foxworth, W. Helferich, and L. Hilakivi-Clarke Excessive Weight Gain during Pregnancy Increases Carcinogen-Induced Mammary Tumorigenesis in Sprague-Dawley and Lean and Obese Zucker Rats J. Nutr., April 1, 2006; 136(4): 998 - 1004. [Abstract] [Full Text] [PDF]

				Y. Takemura, Y. Osuga, M. Harada, T. Hirata, K. Koga, C. Morimoto, Y. Hirota, O. Yoshino, T. Yano, and Y. Taketani Serum adiponectin concentrations are decreased in women with endometriosis Hum. Reprod., December 1, 2005; 20(12): 3510 - 3513. [Abstract] [Full Text] [PDF]

				E. K. Wei, E. Giovannucci, C. S. Fuchs, W. C. Willett, and C. S. Mantzoros Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study J Natl Cancer Inst, November 16, 2005; 97(22): 1688 - 1694. [Abstract] [Full Text] [PDF]

				S. Otake, H. Takeda, Y. Suzuki, T. Fukui, S. Watanabe, K. Ishihama, T. Saito, H. Togashi, T. Nakamura, Y. Matsuzawa, et al. Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance Clin. Cancer Res., May 15, 2005; 11(10): 3642 - 3646. [Abstract] [Full Text] [PDF]

				M. Ishikawa, J. Kitayama, S. Kazama, T. Hiramatsu, K. Hatano, and H. Nagawa Plasma Adiponectin and Gastric Cancer Clin. Cancer Res., January 15, 2005; 11(2): 466 - 472. [Abstract] [Full Text] [PDF]